DCF — GREATER BALTIMORE MEDICAL CENTER
Enterprise Value: $-371.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-371.7M
Enterprise Value
$-124.3M
PV of Cash Flows
$-247.4M
PV of Terminal Value
$-398.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $432.9M | $-19.5M | -4.0% | $-37.8M | $-34.4M |
| Year 2 | $445.9M | $-15.6M | -3.0% | $-34.5M | $-28.5M |
| Year 3 | $459.2M | $-11.5M | -2.0% | $-30.9M | $-23.2M |
| Year 4 | $473.0M | $-9.5M | -2.0% | $-29.5M | $-20.1M |
| Year 5 | $487.2M | $-8.5M | -2.0% | $-29.1M | $-18.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-371.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$420.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.049999999643082375
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5